Litcius/Paper detail

Melatonin reduces neuropathic pain behavior and glial activation through MT2 melatonin receptor modulation in a rat model of lysophosphatidylcholine-induced demyelination neuropathy

Chun‐Ta Huang, Seu‐Hwa Chen, Chi-Fen Chang, Shih‐Chang Lin, June‐Horng Lue, Yi‐Ju Tsai

2020Neurochemistry International18 citationsDOI

Topics & Concepts

Glial fibrillary acidic proteinEndocrinologyInternal medicineMelatoninAstrocyteMelatonin receptorNeuropathic painMicrogliaReceptor antagonistMAPK/ERK pathwayMedicineAntagonistReceptorBiologyPharmacologySignal transductionInflammationCentral nervous systemImmunohistochemistryCell biologyPain Mechanisms and TreatmentsPharmacological Effects of Natural CompoundsDermatology and Skin Diseases
Melatonin reduces neuropathic pain behavior and glial activation through MT2 melatonin receptor modulation in a rat model of lysophosphatidylcholine-induced demyelination neuropathy | Litcius